15 WiSys Technologies in "Education & Training" or "Information Technology" or "Pharmaceuticals & Vitamin D"
WiSys is actively seeking a commercial partner who is interested in licensing this educational resource package. Access to all materials including the beta version of the software is available for evaluation by interested parties.
WiSys is seeking a strategic partner skilled in the manufacturing and distribution of whiteboards who could provide a route to market for the commercialization and use of this single sweep whiteboard eraser. The current prototype can be added to previously installed whiteboards, but with additional development could be incorporated into the whiteboard design as one complete package.
WiSys is currently seeking strategic partners in the golf training aid and accessories market that are interested in further developing this golf swing improvement tool for production-scale manufacturing, ultimately providing a path to market for commercialization.
WiSys is seeking strategic partners interested in additional development, production scale-up, marketing and distribution of this music theory board game and electronic app. Opportunities may exist for development of derivative works.
WiSys is seeking a strategic industry partner for further development, manufacturing, sales, and distribution of this device, which allows the user to visualize and better understand the physical concepts of mechanical impedance, momentum, and energy conservation.
WiSys Technology Foundation is seeking a commercial partner who is interested in licensing and distributing an educational app focused on Physics, expanding the platform beyond Android applications as well as further developing additional apps directed towards other STEM disciplines.
WiSys Technology Foundation is seeking a strategic partner for manufacturing, marketing, sales, and distribution of a lift that allows para-equestrian riders to independently saddle their horses.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.